NASDAQ:FWPAY

Forward Pharma A/S (FWPAY) Stock Price, News & Analysis

Notice: This company has been marked as potentially delisted and may not be actively trading.
Today's Range
$300.00
$400.00
50-Day Range
$2.00
$800.00
52-Week Range
$1.43
$5.33
Volume
11 shs
Average Volume
7 shs
Market Capitalization
$6 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A

About Forward Pharma A/S

Forward Pharma A/S is a biopharmaceutical company, which engages in the research and development of medicinal treatment for inflammatory and neurological indications. It focuses on the immunomodulatory compound dimethyl fumarate and its derivatives. The company was founded by Florian Schönharting on July 2005 and is headquartered in Copenhagen, Denmark.

FWPAY Stock News Headlines

The Analyst Landscape: 4 Takes On Forward Air
Protect Yourself While There’s Still Time …
The next step of the Fed's control is here. Section 702 of the Foreign Intelligence Surveillance Act was renewed for two more years and passed into law earlier this week. Allowing the Fed to tighten its grip on your personal privacy and freedom.
Spring forward -- daylight savings time is here!
Pay It Forward: Sydney & Mike’s Angels
See More Headlines
Receive FWPAY Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Forward Pharma A/S and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Today
4/26/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
N/A
Current Symbol
NASDAQ:FWPAY
Web
N/A
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A

Miscellaneous

Free Float
7,000
Market Cap
$6 million
Optionable
Not Optionable
Beta
-42.67
A Guide To High-Short-Interest Stocks Cover

MarketBeat's analysts have just released their top five short plays for May 2024. Learn which stocks have the most short interest and how to trade them. Click the link below to see which companies made the list.

Get This Free Report

Key Executives

  • Claus Bo Svendsen
    CEO & Principal Financial Officer
  • Thomas Carbone
    Principal Accounting Officer & VP-Finance

FWPAY Stock Analysis - Frequently Asked Questions

When did Forward Pharma A/S's stock split?

Forward Pharma A/S's stock reverse split on the morning of Thursday, June 8th 2023. The 1-285.7139 reverse split was announced on Thursday, June 8th 2023. The number of shares owned by shareholders was adjusted after the market closes on Thursday, June 8th 2023. An investor that had 100 shares of stock prior to the reverse split would have 0 shares after the split.

This page (NASDAQ:FWPAY) was last updated on 4/26/2024 by MarketBeat.com Staff

From Our Partners